UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,428.40 -10.10 (-0.41%) DOW
39,863.31 +56.54 (+0.14%) Bitcoin GBP
54,480.04 -224.00 (-0.41%)
Benitec Biopharma Limited (BNTC)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:37PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 98.08M |
| Enterprise value | 84.29M |
| Trailing P/E | 51.55 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.41k |
| Price/book (mrq) | 8.53 |
| Enterprise value/revenue | 12.04k |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.81 |
| 52-week change 3 | 193.28% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 10.70 |
| 52-week low 3 | 1.86 |
| 50-day moving average 3 | 6.60 |
| 200-day moving average 3 | 4.07 |
Share statistics
| Avg vol (3-month) 3 | 91.19k |
| Avg vol (10-day) 3 | 35.62k |
| Shares outstanding 5 | 9.37M |
| Implied shares outstanding 6 | 9.37M |
| Float 8 | 1.57M |
| % held by insiders 1 | 10.42% |
| % held by institutions 1 | 45.05% |
| Shares short (30 Apr 2024) 4 | 98.53k |
| Short ratio (30 Apr 2024) 4 | 0.49 |
| Short % of float (30 Apr 2024) 4 | 1.26% |
| Short % of shares outstanding (30 Apr 2024) 4 | 1.16% |
| Shares short (prior month 28 Mar 2024) 4 | 10.96k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 18 Nov 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:17 |
| Last split date 3 | 26 Jul 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -35,560.66% |
Management effectiveness
| Return on assets (ttm) | -81.53% |
| Return on equity (ttm) | -178.30% |
Income statement
| Revenue (ttm) | 61k |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.6M |
| Net income avi to common (ttm) | -21.81M |
| Diluted EPS (ttm) | -236.13 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 20.37M |
| Total cash per share (mrq) | 7.86 |
| Total debt (mrq) | 423k |
| Total debt/equity (mrq) | 2.73% |
| Current ratio (mrq) | 3.62 |
| Book value per share (mrq) | 5.97 |
Cash flow statement
| Operating cash flow (ttm) | -18.07M |
| Levered free cash flow (ttm) | -9.6M |
© 2024 Yahoo. All rights reserved.